Showing results (241-250 of 297) with videos related to

Sort By:
Pageof 30
Scientific Reports|July 19, 2014
Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-κBAmy Chow, Weiying Zhou, Liang Liu, et al.
Frontiers in Immunology|January 21, 2022
High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center StudyLingdi Zhao, Tiepeng Li, Yongping Song, et al.
Clinical Immunology (Orlando, Fla.)|May 7, 2023
OX40 shapes an inflamed tumor immune microenvironment and predicts response to immunochemotherapy in diffuse large B-cell lymphomaYaxiao Lu, Yang Li, Jingwei Yu, et al.
Frontiers in Oncology|August 2, 2021
An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP ChemotherapyYaxiao Lu, Jingwei Yu, Wenchen Gong, et al.
Cancer Biology & Medicine|September 23, 2021
EZH2 identifies the precursors of human natural killer cells with trained immunityChen Zhang, Jie Yin, Jian Zheng, et al.
Journal of Immunology Research|February 25, 2021
Corrigendum to "Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3+ CD8+ T Cells and Survival in Diffuse Large B Cell Lymphoma"Tingting Zhang, Tianyuan Ren, Zheng Song, et al.
Hematological Oncology|May 11, 2019
Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T-cell lymphomasXuhan Zhang, Lu Liu, Shiyong Zhou, et al.
Journal of Immunology Research|November 12, 2020
Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3+ CD8+ T Cells and Survival in Diffuse Large B Cell LymphomaTingting Zhang, Tianyuan Ren, Zheng Song, et al.
Clinical Immunology (Orlando, Fla.)|September 2, 2022
A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphomaXiaoxuan Wang, Yuheng Hong, Shen Meng, et al.
British Journal of Haematology|October 19, 2021
Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNASicong Zhang, Tingting Zhang, Hengqi Liu, et al.
Pageof 30